PBPH ETF
Portfolio Building Block World Pharma and Biotech Index ETF
LLY is PBPH's largest holding at 14.52% of the fund as of Sep 15, 2026. PBPH is Portfolio Building Block World Pharma and Biotech Index ETF.
| # | Ticker | Name | Weight | Cumulative | Shares | Mkt value | Share chg | Sector | Industry |
|---|---|---|---|---|---|---|---|---|---|
| 1 | L | Eli Lilly & Co.Health Care · Pharmaceuticals | 14.52% | 14.5% | 131,060 | $146.22M | +3.2K | Health Care | Pharmaceuticals |
| 2 | J | Johnson & Johnson -Health Care · Pharmaceuticals | 9.86% | 24.4% | 373,986 | $99.32M | +9.7K | Health Care | Pharmaceuticals |
| Share changes, sector and industry · Pro | |||||||||
| 3 | A | AbbVie Inc. | 7.01% | 31.4% | 274,675 | $70.62M | |||
| 4 | M | Merck & Company Inc | 5.45% | 36.8% | 381,470 | $54.90M | |||
| 5 | — | Roche Ps Par Ag | 4.52% | 41.4% | 107,746 | $45.49M | |||
| 6 | A | Amgen Inc. | 4.45% | 45.8% | 118,719 | $44.80M | |||
| 7 | G | Gilead Sciences | 4.08% | 49.9% | 285,722 | $41.06M | |||
| 8 | N | Novartis Ag - Class N | 3.85% | 53.7% | 282,037 | $38.76M | |||
| 9 | P | Pfizer Inc | 3.61% | 57.4% | 1,311,349 | $36.35M | |||
| 10 | — | AstraZeneca PLC | 3.56% | 60.9% | 225,981 | $35.80M | |||
| 11 | N | Novo Nordisk Class B | 3.13% | 64.0% | 733,652 | $31.51M | |||
| 12 | — | Nvaesrtex Pharmaceuticals Inc | 2.98% | 67.0% | 58,247 | $30.02M | |||
| 13 | B | Bristol-Myers Squibb Co. | 2.97% | 70.0% | 469,541 | $29.88M | |||
| 14 | S | Sanofi | 2.11% | 72.1% | 249,868 | $21.26M | |||
| 15 | — | GSK plc | 2.04% | 74.1% | 857,162 | $20.53M | |||
| 16 | R | Regeneron Pharmaceuticals, Inc. | 1.81% | 76.0% | 23,370 | $18.26M | |||
| 17 | — | Csl Ltd | 1.51% | 77.5% | 126,724 | $15.19M | |||
| 18 | — | Argenx Se Sponsored Adr (1 Ads : 1 Ordinary) | 1.41% | 78.9% | 14,276 | $14.16M | |||
| 19 | T | Takeda Pharmaceutical Co. Ltd. Com Stk | 1.31% | 80.2% | 356,151 | $13.15M | |||
| 20 | B | Bayer (Germany) | 1.26% | 81.4% | 226,004 | $12.64M | |||
| 21 | — | Moderna therapeutics | 1.16% | 82.6% | 80,985 | $11.66M | |||
| 22 | N | Natera Inc | 1.02% | 83.6% | 31,212 | $10.27M | |||
| 23 | — | Teva Pharmaceutical Industries Limited (Adr) | 0.97% | 84.6% | 266,246 | $9.77M | |||
| 24 | R | Revolution Medicines Inc | 0.82% | 85.4% | 40,691 | $8.29M | |||
| 25 | S | Sandoz Group Ag | 0.76% | 86.2% | 94,053 | $7.70M | |||
| 26 | A | Alnylam Pharmaceuticals Inc. | 0.75% | 86.9% | 30,349 | $7.55M | |||
| 27 | B | Biogen Inc. | 0.73% | 87.7% | 33,972 | $7.38M | |||
| 28 | I | Illumina, Inc. | 0.72% | 88.4% | 34,883 | $7.20M | |||
| 29 | Z | Zoetis Inc, Class A | 0.70% | 89.1% | 96,645 | $7.05M | |||
| 30 | — | Otsuka Holdings Co., Ltd. Com Stk | 0.69% | 89.8% | 94,474 | $6.98M | |||
| 31 | — | Daiichi Sankyo Co. Ltd. Com Stk | 0.68% | 90.4% | 378,422 | $6.84M | |||
| 32 | — | Ucb Sa | 0.66% | 91.1% | 27,737 | $6.62M | |||
| 33 | I | Insmed Inc | 0.62% | 91.7% | 48,340 | $6.26M | |||
| 34 | — | Chugai Pharmaceutical Co. Ltd. Com Stk | 0.60% | 92.3% | 143,993 | $6.03M | |||
| 35 | — | Astellas Pharma Inc. Com Stk | 0.58% | 92.9% | 398,935 | $5.82M | |||
| 36 | — | Haleon Plc | 0.57% | 93.5% | 1,281,176 | $5.79M | |||
| 37 | I | Incyte Corp. | 0.56% | 94.0% | 46,433 | $5.64M | |||
| 38 | R | Royalty Pharma Plc Class A Ordinary Share | 0.50% | 94.5% | 86,179 | $5.05M | |||
| 39 | U | United Therapeutics Corp | 0.48% | 95.0% | 9,779 | $4.86M | |||
| 40 | — | Roivant Sciences Ltd. Common Shares | 0.45% | 95.5% | 111,270 | $4.54M | |||
| 41 | V | Viatris Inc. | 0.44% | 95.9% | 265,750 | $4.39M | |||
| 42 | G | Genmab A/S | 0.44% | 96.3% | 13,754 | $4.47M | |||
| 43 | N | Neurocrine Biosciences Inc | 0.36% | 96.7% | 22,943 | $3.58M | |||
| 44 | J | Jazz Pharmaceuticals Plc. | 0.34% | 97.0% | 14,082 | $3.46M | |||
| 45 | D | Dreyfus Trsry Securities Cash Management | 0.34% | 97.4% | 3,383,437 | $3.38M | |||
| 46 | E | Exelixis Inc | 0.32% | 97.7% | 56,638 | $3.18M | |||
| 47 | — | Shionogi & Co Ltd | 0.30% | 98.0% | 165,934 | $3.06M | |||
| 48 | R | Roche Holding Ag- Genusschein | 0.30% | 98.3% | 6,934 | $3.00M | |||
| 49 | B | Biomarin Pharmaceutical Inc. | 0.29% | 98.6% | 44,287 | $2.91M | |||
| 50 | E | Elanco Animal Health, Inc Cvr | 0.27% | 98.9% | 116,523 | $2.70M | |||
| More holdings · Pro | |||||||||
PBPH ETF All Holdings
PBPH holdings total 55 positions. The top 10 holdings account for 60.9% of the fund, led by Eli Lilly & Co. at 14.5%, Johnson & Johnson - Common at 9.9%, Abbvie Inc. at 7.0%.
PBPH portfolio concentration is relatively high, with the top 10 representing 60.9% of total assets. The largest sector exposure is Health Care at 71.3%.
PBPH sectors provide a detailed breakdown. PBPH overlap shows how holdings compare to other funds in your portfolio.
PBPH ETF Holdings
54 of 55 holdings
- 1
Eli Lilly & Co.
LLYHealth Care14.52% - 2
Johnson & Johnson - Common
JNJHealth Care9.86% - 3
Abbvie Inc.
ABBVHealth Care7.01% - 4
Merck & Company Inc
MRKHealth Care5.45% - 5
Roche Ps Par Ag
ROP:SMUnknown4.52% - 6
Amgen Inc.
AMGNHealth Care4.45% - 7
Gilead Sciences
GILDHealth Care4.08% - 8
Novartis Ag – Class N
NOVN:SMUnknown3.85% - 9
Pfizer Inc
PFEHealth Care3.61% - 10
AstraZeneca PLC
AZN:LNUnknown3.56% - 11
Novo Nordisk Class B
NOVOB:COUnknown3.13% - 12
Nvaesrtex Pharmaceuticals Inc
VRTXHealth Care2.98% - 13
Bristol-Myers Squibb Co.
BMYHealth Care2.97% - 14
Sanofi
SAN:PAUnknown2.11% - 15
GSK plc
GSK:LNUnknown2.04% - 16
Regeneron Pharmaceuticals, Inc.
REGNHealth Care1.81% - 17
Csl Ltd
CSL:AUUnknown1.51% - 18
Argenx Se Sponsored Adr (1 Ads : 1 Ordinary)
ARGX:ASHealth Care1.41% - 19
Takeda Pharmaceutical Co. Ltd. Com Stk
4502:JPUnknown1.31% - 20
Bayer (Germany)
BAYGN:SGUnknown1.26% - 21
Moderna therapeutics
MRNAHealth Care1.16% - 22
Natera Inc
NTRAHealth Care1.02% - 23
Teva Pharmaceutical Industries Limited (Adr)
TEVA:ILHealth Care0.97% - 24
Revolution Medicines Inc
RVMDHealth Care0.82% - 25
Sandoz Group Ag
SDZ:SMHealth Care0.76% - 26
Alnylam Pharmaceuticals Inc.
ALNYHealth Care0.75% - 27
Biogen Inc. Com
BIIBHealth Care0.73% - 28
Illumina, Inc.
ILMNHealth Care0.72% - 29
Zoetis Inc, Class A
ZTSHealth Care0.70% - 30
Otsuka Holdings Co., Ltd. Com Stk
4578:JPUnknown0.69% - 31
Daiichi Sankyo Co. Ltd. Com Stk
4568:JPUnknown0.68% - 32
Ucb Sa
UCB:BRHealth Care0.66% - 33
Insmed Inc
INSMHealth Care0.62% - 34
Chugai Pharmaceutical Co. Ltd. Com Stk
4519:JPUnknown0.60% - 35
Astellas Pharma Inc. Com Stk
4503:JPUnknown0.58% - 36
Haleon Plc
HLN:LNUnknown0.57% - 37
Incyte Corp.
INCYHealth Care0.56% - 38
Royalty Pharma Plc Class A Ordinary Share
RPD:DUFinancials0.50% - 39
United Therapeutics Corp
UTHRHealth Care0.48% - 40
Roivant Sciences Ltd. Common Shares
ROIV:BMHealth Care0.45% - 41
Viatris Inc.
VTRSHealth Care0.44% - 42
Genmab A/S
0MGB:COUnknown0.44% - 43
Neurocrine Biosciences Inc
NBIXHealth Care0.36% - 44
Jazz Pharmaceuticals Plc.
JAZZHealth Care0.34% - 45
Dreyfus Trsry Securities Cash Mgmt
DIRXXUnknown0.34% - 46
Exelixis Inc
EXELHealth Care0.32% - 47
Shionogi & Co Ltd
4507:JPUnknown0.30% - 48
Roche Holding Ag- Genusschein
RO:SMHealth Care0.30% - 49
Biomarin Pharmaceutical Inc.
BMRNHealth Care0.29% - 50
Elanco Animal Health, Inc Cvr
ELANHealth Care0.27% - 51
Bridgebio Pharma Inc_None_0
BBIOHealth Care0.24% - 52
Galderma
GALD:SMUnknown0.23% - 53
Ionis Pharmaceuticals Inc
IONSHealth Care0.19% - 54
Cash
Other0.03%
| # | Company | Ticker | Sector | Industry | Weight |
|---|---|---|---|---|---|
| 1 | Eli Lilly & Co. | LLY | 14.520% | ||
| 2 | Johnson & Johnson - Common | JNJ | 9.860% | ||
| 3 | Abbvie Inc. | ABBV | 7.010% | ||
| 4 | Merck & Company Inc | MRK | 5.450% | ||
| 5 | Roche Ps Par Ag | ROP:SM | 4.520% | ||
| 6 | Amgen Inc. | AMGN | 4.450% | ||
| 7 | Gilead Sciences | GILD | 4.080% | ||
| 8 | Novartis Ag – Class N | NOVN:SM | 3.850% | ||
| 9 | Pfizer Inc | PFE | 3.610% | ||
| 10 | AstraZeneca PLC | AZN:LN | 3.560% | ||
| 11 | Novo Nordisk Class B | NOVOB:CO | 3.130% | ||
| 12 | Nvaesrtex Pharmaceuticals Inc | VRTX | 2.980% | ||
| 13 | Bristol-Myers Squibb Co. | BMY | 2.970% | ||
| 14 | Sanofi | SAN:PA | 2.110% | ||
| 15 | GSK plc | GSK:LN | 2.040% | ||
| 16 | Regeneron Pharmaceuticals, Inc. | REGN | 1.810% | ||
| 17 | Csl Ltd | CSL:AU | 1.510% | ||
| 18 | Argenx Se Sponsored Adr (1 Ads : 1 Ordinary) | ARGX:AS | 1.410% | ||
| 19 | Takeda Pharmaceutical Co. Ltd. Com Stk | 4502:JP | 1.310% | ||
| 20 | Bayer (Germany) | BAYGN:SG | 1.260% | ||
| 21 | Moderna therapeutics | MRNA | 1.160% | ||
| 22 | Natera Inc | NTRA | 1.020% | ||
| 23 | Teva Pharmaceutical Industries Limited (Adr) | TEVA:IL | 0.970% | ||
| 24 | Revolution Medicines Inc | RVMD | 0.820% | ||
| 25 | Sandoz Group Ag | SDZ:SM | 0.760% | ||
| 26 | Alnylam Pharmaceuticals Inc. | ALNY | 0.750% | ||
| 27 | Biogen Inc. Com | BIIB | 0.730% | ||
| 28 | Illumina, Inc. | ILMN | 0.720% | ||
| 29 | Zoetis Inc, Class A | ZTS | 0.700% | ||
| 30 | Otsuka Holdings Co., Ltd. Com Stk | 4578:JP | 0.690% | ||
| 31 | Daiichi Sankyo Co. Ltd. Com Stk | 4568:JP | 0.680% | ||
| 32 | Ucb Sa | UCB:BR | 0.660% | ||
| 33 | Insmed Inc | INSM | 0.620% | ||
| 34 | Chugai Pharmaceutical Co. Ltd. Com Stk | 4519:JP | 0.600% | ||
| 35 | Astellas Pharma Inc. Com Stk | 4503:JP | 0.580% | ||
| 36 | Haleon Plc | HLN:LN | 0.570% | ||
| 37 | Incyte Corp. | INCY | 0.560% | ||
| 38 | Royalty Pharma Plc Class A Ordinary Share | RPD:DU | 0.500% | ||
| 39 | United Therapeutics Corp | UTHR | 0.480% | ||
| 40 | Roivant Sciences Ltd. Common Shares | ROIV:BM | 0.450% | ||
| 41 | Viatris Inc. | VTRS | 0.440% | ||
| 42 | Genmab A/S | 0MGB:CO | 0.440% | ||
| 43 | Neurocrine Biosciences Inc | NBIX | 0.360% | ||
| 44 | Jazz Pharmaceuticals Plc. | JAZZ | 0.340% | ||
| 45 | Dreyfus Trsry Securities Cash Mgmt | DIRXX | 0.340% | ||
| 46 | Exelixis Inc | EXEL | 0.320% | ||
| 47 | Shionogi & Co Ltd | 4507:JP | 0.300% | ||
| 48 | Roche Holding Ag- Genusschein | RO:SM | 0.300% | ||
| 49 | Biomarin Pharmaceutical Inc. | BMRN | 0.290% | ||
| 50 | Elanco Animal Health, Inc Cvr | ELAN | 0.270% | ||
| 51 | Bridgebio Pharma Inc_None_0 | BBIO | 0.240% | ||
| 52 | Galderma | GALD:SM | 0.230% | ||
| 53 | Ionis Pharmaceuticals Inc | IONS | 0.190% | ||
| 54 | Cash | - | 0.030% |

































